Rheumatoid arthritis pharmacogenomics

被引：1
|
作者：
Marsal, Sara [1 ]
Julia, Antonio [1 ]
机构：
[1] Hosp Vall d Hebron, Grp Recerca Reumatol, Inst Recerca, Barcelona, Spain
来源：
PHARMACOGENOMICS | 2010年 / 11卷 / 05期
关键词：
anti-TNF-alpha therapy; genomics; methotrexate; microarrays; response predictor; rheumatoid arthritis; BLOOD-CELLS; METHOTREXATE; RESPONSIVENESS; INFLIXIMAB; PREDICTS; THERAPY;
D O I：
10.2217/PGS.10.53
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Rheumatoid arthritis is a highly heterogeneous disease in all its aspects, including response to therapy. During the last 10 years, we have seen evidence of the revolution of biological therapies in the treatment of rheumatoid arthritis. However, there is a substantial proportion of patients who do not respond efficiently to some of these therapies. One of the main aims for pharmacogenomics of rheumatoid arthritis for the next few years will be to accurately identify, from available therapies, which is the optimal therapy for any particular individual. The use of more powerful technologies together with the existence of large collections of samples and high-quality associated clinical data will be essential to reach this objective.
引用
收藏
页码：617 / 619
页数：3
相关论文
共 50 条
  • [21] Pharmacogenomics of Anti-TNF Treatment Response Marks a New Era of Tailored Rheumatoid Arthritis Therapy
    Wysocki, Tomasz
    Paradowska-Gorycka, Agnieszka
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (04)
  • [22] The use of low dose methotrexate in rheumatoid arthritis - are we entering a new era of therapeutic drug monitoring and pharmacogenomics?
    Stamp, Lisa
    Roberts, Rebecca
    Kennedy, Martin
    Barclay, Murray
    O'Donnell, John
    Chapman, Peter
    BIOMEDICINE & PHARMACOTHERAPY, 2006, 60 (10) : 678 - 687
  • [23] Preclinical Rheumatoid Arthritis and Rheumatoid Arthritis Prevention
    Kevin D. Deane
    Current Rheumatology Reports, 2018, 20
  • [24] Epidemiology of rheumatoid arthritis: Rheumatoid arthritis and mortality
    Myasoedova E.
    Davis III J.M.
    Crowson C.S.
    Gabriel S.E.
    Current Rheumatology Reports, 2010, 12 (5) : 379 - 385
  • [25] Preclinical Rheumatoid Arthritis and Rheumatoid Arthritis Prevention
    Deane, Kevin D.
    CURRENT RHEUMATOLOGY REPORTS, 2018, 20 (08)
  • [26] Preclinical rheumatoid arthritis and rheumatoid arthritis prevention
    Greenblatt, H. Karl
    Kim, Hyoun-Ah
    Bettner, Leah F.
    Deane, Kevin D.
    CURRENT OPINION IN RHEUMATOLOGY, 2020, 32 (03) : 289 - 296
  • [27] Individualized Prediction of Response to Methotrexate Treatment in Patients with Rheumatoid Arthritis: A Pharmacogenomics-driven Machine Learning Approach
    Myasoedova, Elena
    Athreya, Arjun
    Crowson, Cynthia
    Weinshilboum, Richard
    Wang, Liewei
    Matteson, Eric
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [28] Toward Individualized Prediction of Response to Methotrexate in Early Rheumatoid Arthritis: A Pharmacogenomics-Driven Machine Learning Approach
    Myasoedova, Elena
    Athreya, Arjun P.
    Crowson, Cynthia S.
    Davis, John M.
    Warrington, Kenneth J.
    Walchak, Robert C.
    Carlson, Erin
    Kalari, Krishna R.
    Bongartz, Tim
    Tak, Paul P.
    van Vollenhoven, Ronald F.
    Padyukov, Leonid
    Emery, Paul
    Morgan, Ann
    Wang, Liewei
    Weinshilboum, Richard M.
    Matteson, Eric L.
    ARTHRITIS CARE & RESEARCH, 2022, 74 (06) : 879 - 888
  • [29] PHARMACOGENOMICS-DRIVEN INDIVIDUALIZED PREDICTION OF TREATMENT RESPONSE TO METHOTREXATE IN PATIENTS WITH RHEUMATOID ARTHRITIS: A MACHINE LEARNING APPROACH
    Myasoedova, E.
    Athreya, A.
    Crowson, C. S.
    Weinshilboum, R.
    Wang, L.
    Matteson, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 594 - 594
  • [30] DIFFERENTIAL DIAGNOSIS OF RHEUMATOID-ARTHRITIS AND RHEUMATOID ARTHRITIS AND RHEUMATOID SYNDROME
    VERMEL, AE
    KOCHUBEI, LN
    BYCHKOVA, AI
    MOISEEV, VS
    SOVETSKAYA MEDITSINA, 1972, (10): : 89 - &
12345